Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma-Reference-Cited by-同舟云学术

Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma

Published:2013-11-07 Issue:2 Volume:32 Page:551-557
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Cussenot Olivier,Sighar Karim,Mohammed Mansoor,Hugonin Sylvain,Ondet Valérie,Larre Stéphane,Lacave Roger,Roupret Morgan,Cancel-Tassin Géraldine

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-013-1191-3/fulltext.html

Reference24 articles.

1. Green DA, Rink M, Cha EK, Xylinas E, Chughtai B, Scherr DS, Shariat SF, Lee RK (2013) Cost-effective treatment of low-risk carcinoma not invading bladder muscle. BJU Int 111(3 Pt B):78–84

2. Schäfauer C, Ettori D, Rouprêt M, Phé V, Tualle JM, Tinet E, Avrillier S, Egrot C, Traxer O, Cussenot O (2013) Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. J Urol 190(1):271–277. doi: 10.1016/j.juro.2013.01.100

3. Stenzl A, Penkoff H, Dajc-Sommerer E, Zumbraegel A, Hoeltl L, Scholz M, Riedl C, Bugelnig J, Hobisch A, Burger M, Mikuz G, Pichlmeier U (2011) Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : a multicenter randomized, double-blind, placebo-controlled trial. Cancer 117(5):938–947

4. Schrag D, Hsieh LJ, Rabbani F, Bach PB, Herr H, Begg CB (2003) Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst 95:588

5. Zhang Y, Denton BT, Nielsen ME (2013) Comparison of surveillance strategies for low-risk bladder cancer patients. Med Decis Mak 33(2):198–214

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urine biomarkers in bladder cancer — current status and future perspectives;Nature Reviews Urology;2023-05-24

2. Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?;Translational Andrology and Urology;2021-06

3. Corrélation des altérations génétiques à l’agressivité anatomo-pathologique des carcinomes urothéliaux de la vessie : performance du test BCA-1;Progrès en Urologie;2017-06

4. Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma;International Journal of Molecular Sciences;2016-02-24

5. Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA;European Journal of Human Genetics;2016-01-13